Search

Search Constraints

You searched for: Author/Creator Xu, Mingjun

Search Results

7. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial. Issue 8 (August 2021)